Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Systematic Review

Published on 31 Jan 2025

How much can we save by applying artificial intelligence in evidence synthesis? Results from a pragmatic review to quantify workload efficiencies and cost savings

in Drugs Outcomes Research and Policies

Seye Abogunrin
Jeffrey M. Muir
Clarissa Zerbini
Grammati Sarri

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1454245

1,863 views

Original Research

Published on 29 Jan 2025

Challenging the curve: can ChatGPT-generated MCQs reduce grade inflation in pharmacy education

in Drugs Outcomes Research and Policies

Dalia Almaghaslah

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1516381

1,221 views

Original Research

Published on 29 Jan 2025

Hemoglobin-to-red blood cell distribution width ratio as a protective factor against coronary artery disease: a cross-sectional analysis of NHANES (2011-2018)

in Drugs Outcomes Research and Policies

Xin-Da Wang
Chaoya Li
Jia Hu
Fen Cao
Li Zhu
Yongzhi Zhu
Zhongzheng Wen
Jun Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1534479

1,072 views

Original Research

Published on 24 Jan 2025

Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned survival model

in Drugs Outcomes Research and Policies

Gang Fang
Zhipeng Pi
Yiping An
Xinxin Cao
Wei Li
Xiangjun Zhu
Jinxi Ding

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1400422

965 views

Systematic Review

Published on 23 Jan 2025

Comparative efficacy and safety of 20 intravenous pharmaceutical intervention for prevention of etomidate-induced myoclonus: a systematic review and Bayesian network meta-analysis

in Drugs Outcomes Research and Policies

Lu Chen
Pengxiang Zhou
Zhengqian Li
Ziyang Wu
Suodi Zhai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1507616

918 views

Original Research

Published on 22 Jan 2025

Drivers of innovation value: simulation for new drug pricing evaluation based on system dynamics modelling

in Drugs Outcomes Research and Policies

Qian Xing
Wendi Cheng
Wei Wang
Chunlin Jin
Haiyin Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1474856

886 views

Original Research

Published on 22 Jan 2025

Exploring the hemoglobin-to-red blood cell distribution width ratio (HRR) to peripheral arterial disease nexus: a comprehensive analysis of NHANES data from 1999 to 2004

in Drugs Outcomes Research and Policies

Zhihai Yu
Bin Lu
Rui Han
Can Tu

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1529155

1,234 views

Original Research

Published on 20 Jan 2025

Towards implementing new payment models for the reimbursement of high-cost, curative therapies in Europe: insights from semi-structured interviews

in Drugs Outcomes Research and Policies

Thomas Desmet
Sissel Michelsen
Elena Van den Brande
Walter Van Dyck
Steven Simoens
Isabelle Huys

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397531

1,024 views

Original Research

Published on 15 Jan 2025

Adding capivasertib to fulvestrant in patients with hormone receptor-positive advanced breast cancer: a cost-effectiveness analysis

in Drugs Outcomes Research and Policies

Yitian Lang
Qingqing Chai
Yan Lin
Bin Wu
Xiaoyan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1495082

1,436 views

Original Research

Published on 15 Jan 2025

The efficacy and safety of first-line monotherapies in primary therapy of invasive aspergillosis: a systematic review

in Drugs Outcomes Research and Policies

Yan Chen
Jiaojiao Zhao
Yifei Wang
Long Ge
Joey Sum-wing Kwong
Junjie Lan
Rui Zhang
Huaye Zhao
Linfang Hu
Jiaxue Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1530999

1,193 views

Review

Published on 14 Jan 2025

Discussion on the optimization of personalized medication using information systems based on pharmacogenomics: an example using colorectal cancer

in Drugs Outcomes Research and Policies

Mengying Yuan
Yuankun Zheng
Fei Wang
Niuniu Bai
Haoling Zhang
Yuan Bian
Hao Liu
Xia He

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1516469

669 views
1 citation

Original Research

Published on 10 Jan 2025

Survival analysis of a 16-year cohort of follicular lymphoma patients receiving systemic treatment in Brazil

in Drugs Outcomes Research and Policies

Pamela Santos Azevedo
Isabella Zuppo Laper
Deborah Marta do Santos Oliveira
Adriano de Paula Sabino
Marina Morgado Garcia
Isabela Cristina Menezes de Freitas
Wallace Mateus Prata
Mariângela Leal Cherchiglia
Juliana Álvares-Teodoro
Francisco de Assis Acurcio

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1414244

812 views

Systematic Review

Published on 08 Jan 2025

Efficacy and safety of anticoagulants on venous thromboembolism: a systematic review and network meta-analysis of randomized controlled trials

in Drugs Outcomes Research and Policies

Weijie Fu
Maolin Zhao
Sheng Ding
Mei Xin
Ke Yang
Li Jiang
Fan Wu
Xiaochen Wu
Jian Wang
Jie Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1519869

1,332 views

Original Research

Published on 07 Jan 2025

Appropriateness and inappropriate medication predictors of stress ulcer prophylaxis in the intensive care unit

in Drugs Outcomes Research and Policies

Pan Zhang
Siyang Wang
Tingting Zhi
Naobei Ye
Haonan Sun
Xingyu Qin
Shuhan Xu
Ruiqin Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1401335

706 views

Original Research

Published on 07 Jan 2025

Analysis of factors influencing the awareness of inpatients regarding hospital clinical pharmacy services and willingness to pay: a multicenter survey in Hebei Province, China

in Drugs Outcomes Research and Policies

Ruixia Yang
Xin Wang
Huizhen Wu
Qian Sun
Sijie Zhang
Qian Dong
Mengjiao Li
Xiaoli Xu
Jing Bai
Ping Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1520058

652 views

Original Research

Published on 07 Jan 2025

Doctor, what is my risk of bleeding after cardiac surgery while on combined anticoagulant with antiplatelet therapy? A validated nomogram for risk assessment

in Drugs Outcomes Research and Policies

Haolong Han
Hang Xu
Jifan Zhang
Weihui Zhang
Yi Yang
Xia Wang
Li Wang
Dongjin Wang
Weihong Ge

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1528390

755 views